Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)
Status:
Completed
Trial end date:
2018-03-28
Target enrollment:
Participant gender:
Summary
Evaluate safety and efficacy of iron isomaltoside/ferric derisomaltose (Monofer®/Monoferric®)
compared with iron sucrose (Venofer®), in subjects diagnosed with IDA.
Phase:
Phase 3
Details
Lead Sponsor:
Pharmacosmos A/S
Treatments:
Ferric Compounds Ferric Oxide, Saccharated Iron Iron isomaltoside 1000